Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Positive efficacy results obtained in phase II trial of ALX1-11; phase III trials will begin soon

Sep. 25, 1997

Crinone approved for marketing in Germany

Sep. 25, 1997

Osteoporosis indication for tiludronate dropped

Sep. 25, 1997

Spotlight on bisphosphonates in osteoporosis

Sep. 25, 1997

Novo Nordisk presents potassium channel openers/blockers

Sep. 25, 1997

Study results of Crinone as ART treatment presented

Sep. 24, 1997

Acute vasodilating effects of KDI-792 in diabetics

Sep. 23, 1997

Clinical trials begin with topical impotence treatment

Sep. 23, 1997

BM-41.0904: a potential new osteoanabolic agent

Sep. 23, 1997

New SERMs prepared at Lilly

Sep. 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...